New evidence shows that extended estrogen suppression treatment using an aromatase inhibitors for hormone receptor-positive postmenopausal breast cancer is safe; it does not increase the risk of ...

With advancements in modern medicine, the overall rate of new breast cancer cases has declined a total of 43 percent since 1989, says Breastcancer.org. That is a promising number. However, it can ...

Anti-estrogenic therapies can suppress the growth of cancer that does not express estrogen receptors; when combined with immune checkpoint inhibitor therapies, they halt tumor progression in mice ...

A few weeks ago, River Smith visited his primary care doctor in the Tampa Bay, Florida, area because he needed a new prescription for testosterone and the estrogen blocker he takes as part of his ...